BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND DEK, D6S231E, 7913, ENSG00000124795, P35659
10 results:

  • 1. In silico gene expression and pathway analysis of dek in the human brain across the lifespan.
    Greene AN; Nguyen ET; Paranjpe A; Lane A; Privette Vinnedge LM; Solomon MB
    Eur J Neurosci; 2022 Sep; 56(6):4720-4743. PubMed ID: 35972263
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Radiographic and Hormonal Regression in Prolactinomas: An Analysis of Treatment Failure.
    Akinduro OO; Lu VM; Izzo A; De Biase G; Vilanilam G; Van Gompel JJ; Bernet V; Donaldson A; Olomu O; Meyer FB; Quinones-Hinojosa A; Chaichana KL
    World Neurosurg; 2019 Sep; 129():e686-e694. PubMed ID: 31181361
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Risk of immune-related pneumonitis for PD1/PD-L1 inhibitors: Systematic review and network meta-analysis.
    Huang Y; Fan H; Li N; Du J
    Cancer Med; 2019 May; 8(5):2664-2674. PubMed ID: 30950194
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Sex differences in dek expression in the anterior cingulate cortex and its association with dementia severity in schizophrenia.
    O'Donovan SM; Franco-Villanueva A; Ghisays V; Caldwell JL; Haroutunian V; Privette Vinnedge LM; McCullumsmith RE; Solomon MB
    Schizophr Res; 2018 Dec; 202():188-194. PubMed ID: 30017458
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. dek proto-oncogene is highly expressed in astrocytic tumors and regulates glioblastoma cell proliferation and apoptosis.
    Feng T; Liu Y; Li C; Li Z; Cai H
    Tumour Biol; 2017 Jul; 39(7):1010428317716248. PubMed ID: 28670979
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas.
    Schwetz V; Librizzi R; Trummer C; Theiler G; Stiegler C; Pieber TR; Obermayer-Pietsch B; Pilz S
    Metab Brain Dis; 2017 Feb; 32(1):155-161. PubMed ID: 27525431
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin.
    Klubo-Gwiezdzinska J; Burman KD; Van Nostrand D; Mete M; Jonklaas J; Wartofsky L
    Thyroid; 2012 Mar; 22(3):310-7. PubMed ID: 22313411
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer.
    Wu Q; Hoffmann MJ; Hartmann FH; Schulz WA
    Mol Cancer; 2005 May; 4(1):16. PubMed ID: 15876350
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Epidemiology of childhood brain tumors].
    Michaelis J; Kaletsch U; Kaatsch P
    Zentralbl Neurochir; 2000; 61(2):80-7. PubMed ID: 10986756
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The identification of novel therapeutic targets for the treatment of malignant brain tumors.
    Kroes RA; Jastrow A; McLone MG; Yamamoto H; Colley P; Kersey DS; Yong VW; Mkrdichian E; Cerullo L; Leestma J; Moskal JR
    Cancer Lett; 2000 Aug; 156(2):191-8. PubMed ID: 10880769
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.